Experience

Private Health Management

• United States
• Hospitals and Health Care
• 100 - 200 Employee

• Vice President, ClearCancer

  • Jan 2023 - Present

  For more than 16 years, PHM has delivered exceptional care and outcomes to patients with the most complex cancer cases. We leverage that experience in our ClearCancer suite of solutions, a distinctive service for employers designed to provide clinically sophisticated cancer care to members and cost optimization for organizations. PHM’s ClearCancer suite of solutions includes ClearInsights, an advisory service that uses the ClearCancerIQ™ tool to provide actionable insights that inform the… Show more For more than 16 years, PHM has delivered exceptional care and outcomes to patients with the most complex cancer cases. We leverage that experience in our ClearCancer suite of solutions, a distinctive service for employers designed to provide clinically sophisticated cancer care to members and cost optimization for organizations. PHM’s ClearCancer suite of solutions includes ClearInsights, an advisory service that uses the ClearCancerIQ™ tool to provide actionable insights that inform the development of a targeted strategy to reduce a company’s risk and cost of cancer, and ClearCancer Care Management, which offers the best in personalized cancer care, navigation, and support to employees, resulting in improved clinical outcomes. In my role as Vice President of ClearCancer Solutions, I assist employers in closing the clinical quality gap to improve employee outcomes while reducing wasteful spend. About Private Health Management: PHM is a clinically sophisticated healthcare navigator specializing in serious and complex conditions. The company uses its deep health intelligence and problem-solving expertise to help individuals get well and stay well.

• Managing Director, Health Advisory Practice

  • Jan 2022 - Dec 2022

  Business success depends heavily on the health and productivity of employees. I had the privilege of leading PHM's Health Advisory Practice, providing our corporate clients of all sizes and across a diverse set of industries with health intelligence, risk management, and strategic guidance related to COVID-19 and other health threats, including those from complex and serious conditions like cancer. We advise executive teams, support Chief Medical Officers or serve as an adjunct Chief Health… Show more Business success depends heavily on the health and productivity of employees. I had the privilege of leading PHM's Health Advisory Practice, providing our corporate clients of all sizes and across a diverse set of industries with health intelligence, risk management, and strategic guidance related to COVID-19 and other health threats, including those from complex and serious conditions like cancer. We advise executive teams, support Chief Medical Officers or serve as an adjunct Chief Health Officer.

• Senior Director, Research and Analytics

  • Jan 2021 - Dec 2021

  Designed treatment strategies for patients with complex cancer diagnoses in order to optimize their clinical outcomes.

• Director, Research and Analytics

  • Apr 2019 - Dec 2020



McKinsey & Company

• Business Consulting and Services
• 700 & Above Employee

• Senior Associate

  • Sep 2016 - Aug 2018

  Senior Associate at global management consulting firm working as a trusted advisor to the world's leading businesses and institutions across the private and social sectors. Senior Associate at global management consulting firm working as a trusted advisor to the world's leading businesses and institutions across the private and social sectors.



Memorial Sloan Kettering Cancer Center

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Graduate Student Researcher

  • Mar 2011 - May 2016

  My graduate work focused on Alzheimer's disease drug development. For my thesis, I studied the structure and regulation of γ-secretase, aiming to gain insight into the physiological progression of both Alzheimer's disease (AD) and cancer. I designed and characterized γ-secretase inhibitors (GSIs), which show promise as therapeutics for Notch addicted cancers, and worked on developing γ-secretase modulators (GSMs) that could potentially lead to a cure for AD. To further advance my work… Show more My graduate work focused on Alzheimer's disease drug development. For my thesis, I studied the structure and regulation of γ-secretase, aiming to gain insight into the physiological progression of both Alzheimer's disease (AD) and cancer. I designed and characterized γ-secretase inhibitors (GSIs), which show promise as therapeutics for Notch addicted cancers, and worked on developing γ-secretase modulators (GSMs) that could potentially lead to a cure for AD. To further advance my work, I spearheaded collaborations with a top-3 pharmaceutical company, resulting in the publication of multiple primary research papers as the first author. In total, I’ve published three peer-reviewed papers and had the opportunity to present my findings at one international conference and nine academic symposia. Show less My graduate work focused on Alzheimer's disease drug development. For my thesis, I studied the structure and regulation of γ-secretase, aiming to gain insight into the physiological progression of both Alzheimer's disease (AD) and cancer. I designed and characterized γ-secretase inhibitors (GSIs), which show promise as therapeutics for Notch addicted cancers, and worked on developing γ-secretase modulators (GSMs) that could potentially lead to a cure for AD. To further advance my work… Show more My graduate work focused on Alzheimer's disease drug development. For my thesis, I studied the structure and regulation of γ-secretase, aiming to gain insight into the physiological progression of both Alzheimer's disease (AD) and cancer. I designed and characterized γ-secretase inhibitors (GSIs), which show promise as therapeutics for Notch addicted cancers, and worked on developing γ-secretase modulators (GSMs) that could potentially lead to a cure for AD. To further advance my work, I spearheaded collaborations with a top-3 pharmaceutical company, resulting in the publication of multiple primary research papers as the first author. In total, I’ve published three peer-reviewed papers and had the opportunity to present my findings at one international conference and nine academic symposia. Show less



Weill Cornell Medicine

• United States
• Hospitals and Health Care
• 700 & Above Employee

• Teaching Assistant, Gene Structure and Function

  • Jan 2013 - Jun 2013

  Lectured and graded for Gene Structure and Function, core course of BCMB program (Biochemistry and Structural Biology, Cell and Developmental Biology, and Molecular Biology) Lectured and graded for Gene Structure and Function, core course of BCMB program (Biochemistry and Structural Biology, Cell and Developmental Biology, and Molecular Biology)



New York University

• Higher Education
• 700 & Above Employee

• Research Assistant, Lab of Dr David Stokes

  • Jan 2009 - Jan 2010

  Investigated the 3D structure of the erythrocyte cytoskeleton through high resolution electron tomography. The results of this work were presented as undergraduate thesis. Investigated the 3D structure of the erythrocyte cytoskeleton through high resolution electron tomography. The results of this work were presented as undergraduate thesis.